Impact of esomeprazole and vonoprazan on the antiplatelet effect of clopidogrel and prasugrel, with reference to CYP2C19 genotypes
Phase of Trial: Phase IV
Latest Information Update: 05 Sep 2017
At a glance
- Drugs Clopidogrel (Primary) ; Esomeprazole (Primary) ; Prasugrel (Primary) ; Vonoprazan (Primary)
- Indications Duodenal ulcer; Gastric ulcer; Ischaemic heart disorders; Reflux oesophagitis
- Focus Therapeutic Use
- 05 Sep 2017 Results published in the Clinical Pharmacology and Therapeutics
- 07 Jun 2016 Status changed from active, no longer recruiting to completed.
- 18 May 2016 Status changed from recruiting to active, no longer recruiting.